Pharma Journalist -

Collidion Inc. and CalAsia Pharmaceuticals, Inc., DBA Plex Pharmaceuticals announced that they have entered into a definitive agreement under which Collidion will acquire an 80% equity…
Read More...

Takeda Pharmaceutical Company Limited and Cardurion Pharmaceuticals announced the creation of a new cardiovascular development partnership. Cardurion, a recently launched Boston-area…
Read More...

Flex Pharma has initiated a Phase 2 randomized, controlled, double-blinded, parallel design trial in the US. The COMMEND trial will evaluate FLX-787, the Company’s co-activator of…
Read More...

SiO2 Medical Products, Inc., a U.S.-based designer, developer, manufacturer, and supplier of pharmaceutical packaging, labware, and consumables products, and Sanaria Inc., a U.S.-based…
Read More...

Generex Biotechnology Corporation announced that its wholly-owned subsidiary, Antigen Express, Inc. (www.antigenexpress.com) has entered into a clinical trial collaboration agreement…
Read More...

Zoetis Inc. and Nexvet Biopharma plc announced that Zoetis has completed the acquisition of Nexvet, a biologic therapeutics company developing a pipeline of monoclonal antibody (mAb)…
Read More...

AbbVie Inc said on Friday it had received European approval to market its drug for treatment of all six major forms of hepatitis C. The company said the approval of Maviret was…
Read More...

Otsuka Pharmaceutical Co., Ltd., a wholly owned subsidiary of Otsuka Holdings Co., Ltd. and a global holistic healthcare company dedicated to bettering the health of people worldwide,…
Read More...

CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced that it has entered into a global strategic license with NantCell,…
Read More...

Baxter International Inc., a global medical products company, today announced the completion of the acquisition of Claris Injectables Limited, a global generic injectables…
Read More...